Medicare Enrolled
Dr. Rhonna Lee, ARNP, P.S.
Nurse Practitioner - Primary Care · Spokane, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Rhonna Lee is a nurse practitioner - primary care in Spokane, WA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 612 Medicare services across 422 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $10,009 from 65 pharmaceutical and/or device companies across 366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - primary care. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 23% volume in WA
$10,009 industry payments
Medicare Practice Summary
Medicare Utilization ↗612
Medicare services
Top 23% in WA for nurse practitioner - primary care
422
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
183 | $48 | $135 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
58 | $75 | $195 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
54 | $69 | $113 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
52 | $109 | $197 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
46 | $22 | $40 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
40 | $4 | $21 |
| Annual alcohol misuse screening, 5 to 15 minutes | 40 | $16 | $30 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
40 | $21 | $40 |
| Annual depression screening | 35 | $16 | $30 |
| Pelvic and clinical breast exam for cancer screening A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider. |
19 | $33 | $60 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
16 | $32 | $34 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $26 | $36 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $111 | $270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,009
Total received (2021-2024)
Avg $2,502/year across 4 years
Top 4% in WA for nurse practitioner - primary care
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
366
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,009 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,235
2023
$2,860
2022
$2,667
2021
$2,247
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$290
Lilly USA, LLC
$205
Axsome Therapeutics, Inc.
$203
GlaxoSmithKline, LLC.
$179
Phathom Pharmaceuticals, Inc.
$168
Bayer Healthcare Pharmaceuticals Inc.
$133
AstraZeneca Pharmaceuticals LP
$104
Radius Health, Inc.
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$92
Novo Nordisk Inc
$88
Otsuka America Pharmaceutical, Inc.
$88
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$69
Amgen Inc.
$67
PFIZER INC.
$63
Corium, LLC
$58
Novartis Pharmaceuticals Corporation
$56
Teva Pharmaceuticals USA, Inc.
$52
Dexcom, Inc.
$31
Antares Pharma, Inc.
$28
Kowa Pharmaceuticals America, Inc.
$28
Janssen Pharmaceuticals, Inc
$26
Takeda Pharmaceuticals U.S.A., Inc.
$24
Boston Scientific Corporation
$24
Organon Llc
$22
Mylan Specialty L.P.
$22
Abbott Laboratories
$16
Top 3 companies account for 31.2% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$1,031
ABBVIE INC.
$893
GlaxoSmithKline, LLC.
$630
Lilly USA, LLC
$557
Amgen Inc.
$539
Axsome Therapeutics, Inc.
$429
Janssen Pharmaceuticals, Inc
$420
Otsuka America Pharmaceutical, Inc.
$367
Novo Nordisk Inc
$327
Neurocrine Biosciences, Inc.
$253
PFIZER INC.
$251
MAYNE PHARMA INC.
$218
ITI, Inc.
$211
Corcept Therapeutics
$197
Radius Health, Inc.
$196
Boehringer Ingelheim Pharmaceuticals, Inc.
$189
AbbVie Inc.
$189
Lundbeck LLC
$186
Phathom Pharmaceuticals, Inc.
$168
Biohaven Pharmaceutical Holding Company Ltd.
$157
Takeda Pharmaceuticals U.S.A., Inc.
$137
Bayer Healthcare Pharmaceuticals Inc.
$133
Ascendis Pharma Inc
$125
Ultragenyx Pharmaceutical Inc.
$125
Teva Pharmaceuticals USA, Inc.
$123
Astellas Pharma US Inc
$116
Kowa Pharmaceuticals America, Inc.
$112
Alkermes, Inc.
$108
Novartis Pharmaceuticals Corporation
$100
Biohaven Pharmaceuticals, Inc.
$93
SANOFI-AVENTIS U.S. LLC
$91
Abbott Laboratories
$87
Mylan Specialty L.P.
$86
Sunovion Pharmaceuticals Inc.
$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$69
Corium, LLC
$69
Merck Sharp & Dohme Corporation
$69
Merck Sharp & Dohme LLC
$66
Supernus Pharmaceuticals, Inc.
$50
Amarin Pharma Inc.
$48
BOSTON SCIENTIFIC CORPORATION
$47
Bayer HealthCare Pharmaceuticals Inc.
$47
Vanda Pharmaceuticals Inc.
$46
Antares Pharma, Inc.
$42
Agile Therapeutics, Inc.
$38
Hologic, LLC
$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$37
Exact Sciences Corporation
$34
Nevro Corp.
$33
Dexcom, Inc.
$31
Esperion Therapeutics, Inc.
$30
Almatica Pharma LLC
$29
Medtronic, Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$25
IMPEL PHARMACEUTICALS INC.
$24
Daiichi Sankyo Inc.
$24
Boston Scientific Corporation
$24
Organon Llc
$22
JAZZ PHARMACEUTICALS INC.
$22
Medicure Pharma Inc.
$20
Stryker Corporation
$18
Hologic Sales and Service, LLC
$16
Collegium Pharmaceutical, Inc.
$16
VistaPharm, Inc.
$15
TherapeuticsMD, Inc.
$15
Top 3 companies account for 25.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AIRSUPRA · ANNOVERA · ANORO ELLIPTA · APTIMA · AREXVY · AUSTEDO · AZSTARYS · Aimovig · Austedo XR · Auvelity · Azstarys · BELSOMRA · BEXSERO · BREZTRI · Belbuca · CAPLYTA · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · Crysvita · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL 9 · GEMTESA · GRALISE · HETLIOZ · INGREZZA · INJECTAFER · INVEGA SUSTENNA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · LO LOESTRIN FE · LONHALA MAGNAIR · LYBALVI · Livalo · MOUNJARO · NEXLETOL · NEXPLANON · NOCDURNA · NURTEC ODT · ORIAHNN · OSTEOCOOL RF ABLATION SYSTEM · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR 13 · QELBREE · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYBELSUS · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPINEJACK · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNTHROID · Seglentis · Senza · Sunosi · THINPREP 2000 PROCESSOR · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thyquidity · Trudhesa · Twirla · Tymlos · UBRELVY · VOQUEZNA · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · WATCHMAN · WATCHMAN FLX · Wegovy · XIFAXAN · XYOSTED · YUPELRI · Yupelri · ZEPBOUND · ZORYVE · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for nurse practitioner - primary care in WA.
Geographic Context
Nurse practitioner - primary cares within 10 mi
24
Per 100K population
4.4
County median income
$73,513
Nearest hospital
PROVIDENCE HOLY FAMILY HOSPITAL
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 23% in WA), with low-engagement industry engagement in the top 4% of WA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lee performed 183 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $10,009 from 65 companies across 366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other nurse practitioner - primary cares in Spokane?
Dr. Lee's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Nurse Practitioner - Primary Cares in Spokane
Browse nurse practitioner - primary cares in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Nurse Practitioner - Primary Cares in WA
Nurse practitioner - primary cares ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nurse Practitioner - Primary Cares in WA
Which WA nurse practitioner - primary cares receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology